Other
Common Stock, Shares, Outstanding
Roivant Sciences Common Stock, Shares, Outstanding increased by 2.9% to $709.69M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.4%, from $719.63M to $709.69M. Over 4 years (FY 2020 to FY 2024), Common Stock, Shares, Outstanding shows relatively stable performance with a 1.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2015
Last reportedQ1 2026
How to read this metric
A decrease indicates share buybacks, which can boost EPS, while an increase suggests equity issuance, which may dilute existing shareholders.
Detailed definition
This is the total number of common shares held by all shareholders, excluding treasury shares. It is the primary denomin...
Peer comparison
Standardized metric used globally to assess equity dilution and ownership structure.
Metric ID:
other_common_stock_shares_outstandingHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $222.67M | $684.79M | $692.01M | $694.98M | $701.17M | $704.39M | $726.80M | $760.14M | $767.14M | $800.79M | $804.89M | $806.68M | $739.05M | $733.33M | $719.63M | $695.94M | $682.23M | $689.70M | $709.69M |
| QoQ Change | — | +207.5% | +1.1% | +0.4% | +0.9% | +0.5% | +3.2% | +4.6% | +0.9% | +4.4% | +0.5% | +0.2% | -8.4% | -0.8% | -1.9% | -3.3% | -2.0% | +1.1% | +2.9% |
| YoY Change | — | — | — | — | +214.9% | +2.9% | +5.0% | +9.4% | +9.4% | +13.7% | +10.7% | +6.1% | -3.7% | -8.4% | -10.6% | -13.7% | -7.7% | -5.9% | -1.4% |
Range$222.67M – $806.68M
CAGR+29.4%
Avg YoY Growth+14.7%
Median YoY Growth+2.9%
Current Streak2 quarters growth
Common Stock, Shares, Outstanding at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's common stock, shares, outstanding?
- Roivant Sciences (ROIV) reported common stock, shares, outstanding of $709.69M in Q4 2025.
- How has Roivant Sciences's common stock, shares, outstanding changed year-over-year?
- Roivant Sciences's common stock, shares, outstanding decreased by 1.4% year-over-year, from $719.63M to $709.69M.
- What is the long-term trend for Roivant Sciences's common stock, shares, outstanding?
- Over 4 years (2020 to 2024), Roivant Sciences's common stock, shares, outstanding has grown at a 1.7% compound annual growth rate (CAGR), from $651.58M to $695.94M.
- What does common stock, shares, outstanding mean?
- The total number of shares of common stock currently held by all shareholders.